Moreover, TGF-β is known to hinder CD8 T cell cytotoxic function via a SMAD dependent inhibition of target genes encoding perforins, granzymes and interferon and restrict trafficking of immune cells to the tumor through the downregulation of CD8+ T cell expression of CXCR3 [120]. Here, CD8A is linked to neoplasm.